Lawsuits Allege Zantac Use Caused Cancer
Zantac is one of many medications used to decrease the symptoms of heartburn and acid reflux. In exchange, however, some patients might develop cancer or experience Zantac cancer symptoms. The kind of cancer Zantac can cause is frightening. In fact, the risk of Zantac cancers has caused the FDA to request that manufacturers remove all ranitidine and Zantac products from the shelves. The company has stated that Zantac will not return. If you or a loved one has already taken Zantac and developed cancer, learn about your legal options by speaking with an experienced product liability lawyer today.
The Zantac cancer connection is simply too great to ignore. We are a national law firm focused on holding manufacturers of dangerous drugs responsible for their corporate negligence through Zantac cancer lawsuits. Our lawyers believe that Sanofi failed to warn consumers of the unacceptable levels of a potential human carcinogen (a substance that promotes the formation of cancer) known as NDMA and should be held accountable.
- Lawsuits Allege Zantac Use Caused Cancer
- How Dolman Law Group Can Help With Your Zantac Cancer Lawsuit
- Zantac Cancer Lawsuit MDL Status
- What Is Zantac?
- NDMA: A Probable Human Carcinogen
- NDMA Previously Found in Other Medications
- Zantac and Cancer: Why Is Zantac Still on the Market?
- NDMA's Link to Cancers
- Ranitidine and Bladder Cancer
- What Cancer Does Zantac Cause?
- Zantac Breast Cancer Link
- Zantac Liver Cancer Link
- Common Zantac Cancer Symptoms
- The Damages Caused by Zantac Cancer
- Are You at Risk of Getting Cancer from Zantac?
- Zantac Recalls in the U.S.
- When Do You Need to Hire a Zantac Cancer Lawyer?
- What is the Statute of Limitations for a Zantac Cancer Claim?
- Read What Leading Attorneys Say About Hiring a Zantac Cancer Attorney
- Contact an Experienced Zantac Cancer Attorney
How Dolman Law Group Can Help With Your Zantac Cancer Lawsuit
After a Zantac cancer diagnosis, knowing you are not alone is important. Many individuals suffer from the same illnesses and complications after taking ranitidine. The key is to find a law firm that can offer you the support and legal guidance you need during this time to help you obtain the compensation you deserve.
Filing a Zantac cancer lawsuit is not easy and can take considerable time and legal experience. Your time is better spent focusing on your health and your treatment. Let an experienced Zantac Cancer Lawyer at our law firm focus their efforts on collecting the evidence you need and filing your claim.
Drug companies whose negligence seriously harms patients and consumers should be held accountable. Thousands of Zantac lawsuits are currently being filed across the country. At Dolman Law Group, we understand the impact of Zantac on people who develop cancer. You may have just been trying to heal your heartburn, but ended up with a much worse illness. Our Zantac cancer attorneys will work to hold Zantac manufacturers accountable for failure to warn, design defects, or manufacturing defects.
Allow our experienced product liability lawyers to focus their efforts on collecting the evidence to prove negligence caused cancer. We will keep in constant communication to ensure the claims process aligns with your recovery process.
Zantac Cancer Lawsuit MDL Status
The Zantac Lawsuit MDL (multidistrict litigation) is presently pending before Judge Rosenberg in the United States Federal Court For The Southern District of Florida. This serves the purpose of consolidating each and every Zantac cancer lawsuit before one judge and one courtroom in America. Lead counsel for the Zantac MDL includes Robert Gilbert, Tracy Finken Magnotta, Michael McGlamry, and Adam Pulaski.
Attorneys and injured patients recently filed Zantac cancer lawsuits throughout the United States. In fact, Attorney Dolman Law Group is presently investigating several hundred claims of being diagnosed with cancer as a result of using Zantac. Zantac litigation is in its infancy and scientific hearings (known as Daubert hearings) are still forthcoming.
The purpose of the Daubert hearings is to determine the strength of a correlation between the use of Zantac and the various types of cancer. These hearings will determine whether there is legitimate and strong scientific evidence (generally peer-reviewed medical studies backed up by the testimony of recognized experts) to prove that a specific cancer was likely to have been caused (causal relationship) with the use of Zantac.
Zantac Cancer Lawsuit Update July 7th, 2021
Judge Rosenberg dismissed all pending claims against several manufacturers of generic Zantac, including Teva Pharmaceuticals USA, Par Pharmaceutical Inc., and Amneal Pharmaceuticals, LLC. Judge Rosenberg stated, “State law would require them to redesign or re-label ranitidine products, which they could not do under their federal duty of sameness,”
Rosenberg wrote. “They were not required to stop selling the products in order to comply with both federal and state law. Thus, the failure-to-warn and negligence claims are preempted.” Thus, she cited the preemption argument that is being utilized with continuing success by the pharmaceutical industry.
Zantac Cancer Lawsuit Update July 1st, 2021
Judge Rosenberg dismissed large portions of the multidistrict litigation claims that the heartburn-aiding drug Zantac allegedly causes cancer. Not to worry; this does not mean that you don't have a claim. In fact, plaintiffs' lawyers believe a large majority of the claims will be moving forward.
The types of claims that were dismissed fell under the U.S. Racketeer Influenced and Corrupt Organizations Act (RICO), along with medical monitoring claims seeking the reimbursement of costs for future diagnostic cancer testing. For instance, Judge Rosenberg's reasoning for dismissing the RICO claims was on the basis that the consumers did not purchase Zantac directly from the manufacturers and therefore did not have standing. Regarding medical monitoring, that claim was dismissed altogether, as Judge Rosenberg having already found that such a claim did not belong in the class complaint.
Additionally, Judge Rosenberg also removed the distributors of Zantac, such as CVS and Rite Aid, from any and all personal injury claims against them and dismissed claims filed under the innovator liability theory, which creates liability for brand companies in the labeling of generic medications. In this situation, Judge Rosenberg found that the plaintiffs had failed to show negligence in terms of the manner in which the ranitidine products were stored and transported and whether they were exposed to high temperatures.
On the surface, these dismissals may appear to be a "doom and gloom" moment for the plaintiffs. However, outside the aforementioned, Judge Rosenberg stated that "most of the other dozen-plus claims contain enough factual content, accepted as true, renders the plaintiffs' claims plausible." Some of these claims include negligence, wrongful death, and design defect—all of which, therefore, will likely be moving forward in the process.
The Future of Zantac Cancer Lawsuit Litigation
Overall, these rulings were outlined in six orders and greatly reduced the scope of the litigation, with a stronger emphasis on brand manufacturers, such as GlaxoSmithKline, Pfizer Inc., Sanofi-Aventis, and Boehringer Ingelheim. Nonetheless, Judge Rosenberg has set a bellwether trial deadline of October 1, 2021.
A bellwether trial is essentially a "test trial" that involves a case from a large pool of claims filed against a particular party (or group of parties). The purpose of a bellwether trial is to serve as a "test case" in an effort to foresee how the future of the case may play out.
As with any mass tort lawsuit, the process is generally a few years at a minimum. Chances are it could take as long as five years before we see a Zantac lawsuit payout. If you are considering filing a claim for being diagnosed with cancer after years of using Zantac, contact us immediately. Our Zantac lawsuit team is fielding calls throughout the Country.
What Is Zantac?
Zantac, known as ranitidine in its generic form, is a well-established and widely used over-the-counter and prescription medication to fight heartburn, gastroesophageal reflux disease (GERD), and peptic ulcer disease. First introduced in 1981 by the Glaxo organization before it became GlaxoSmithKline (GSK), it was the world's biggest-selling prescription drug in 1988 before it became available for over-the-counter use. Other manufacturers include Sanofi, Pfizer, Johnson & Johnson, Boehringer, and Ingelheim Pharmaceuticals.
Even though several more effective medications have eclipsed Zantac, it is still widely used and less expensive than the others. It was the 50th most prescribed medication in the United States, with more than 15 million prescriptions in 2016.
The manufacture and distribution of this popular acid reducer came to a halt in September 2019 as the toxin N-nitrosodimethylamine (NDMA) was found in the drug from several different manufacturers. This nitrosamine impurity is a possible human carcinogen, even at low levels.
Currently, there is not enough scientific evidence for the United States Food and Drug Administration (FDA) to determine how long NDMA has been present in ranitidine. If you currently take this medication or used it in the past, and you think you are experiencing Zantac cancer symptoms, contact your physician or another health care professional. You should discuss your treatment options and contact a dangerous drugs lawyer at our firm to determine your course of action.
NDMA: A Probable Human Carcinogen
N-nitrosodimethylamine (NDMA) is a yellow, odorless liquid chemical found in water, soil, and air. Multiple manufacturing processes and water chlorination create it. According to the World Health Organization, NDMA is considered a human carcinogen that can lead to the development of cancer risks among those who consume it at sufficiently high levels.
NDMA can also be formed during the cooking of foods, especially food such as cured meats and fish, as they contain sodium nitrite as a preservative. It is also found in:
- Alcoholic beverages
- Rubber products
- Tobacco smoke
Preliminary testing by the FDA shows some samples of Zantac and ranitidine contain higher levels of NDMA than food. Although human studies are limited, NDMA is listed as a probable carcinogen to both animals and humans. It is still unknown how ranitidine was contaminated with NDMA, as found in laboratory tests.
It is also possible that generic versions of Zantac are contaminated with NDMA when manufactured in other countries without strict quality control standards. The Food and Drug Administration reports that its independent testing has shown that the heartburn medications Pepcid, Tagamet, Nexium, Prevacid, and Prilosec do not contain the chemical NDMA.
NDMA Previously Found in Other Medications
Angiotensin II Receptor blockers, including Valsartan, Losartan, and Irbesartan, were also recalled for NDMA contamination in 2018. In studies with these drugs, there did not seem to be a link to an increased short-term risk of getting cancer, but there was an increased risk of some single cancer outcomes observed.
Further studies are warranted, and until more information is available, many patients are steering clear of Zantac and opting for alternative medications such as Prevacid or Prilosec, which the FDA says are not contaminated with NDMA.
Zantac and Cancer: Why Is Zantac Still on the Market?
The American College of Gastroenterology reports that as many as 60 million Americans suffer from heartburn each month. Considering this fact, it is no wonder drug manufacturers are cashing in on their discomfort. While people who suffer from heartburn can reduce or eliminate their symptoms through dietary changes and stress management, these methods take time to work.
Studies have shown that when ranitidine mixes with the gastric fluid and sodium nitrites that stimulate the digestion process, high amounts of NDMA are produced. Valisure, an independent pharmacy, conducted an extensive study of ranitidine (a generic form of Zantac) in 2019. Their findings illustrated that a single ranitidine tablet contains in excess of 300,000 nanograms of N-Nitrosodimethylamine (NDMA). To put that in proper context, the FDA-approved level of NDMA is 96 nanograms per single tablet. Thus, a single dosage of Zantac contained 3000 times the acceptable level of NDMA. Hence, why the Food and Drug Administration (FDA) pulled all versions of the popular heartburn drugs from shelves on April 1, 2020. The FDA determined that allowing Zantac to remain on the shelves put consumer health and safety at risk.
NDMA's Link to Cancers
The concern with NDMA is that it can potentially cause cancer, even in small amounts. The longer the exposure to this carcinogen, the higher the chances are of developing cancer and other health problems such as liver disease. Rodent studies revealed a consistent carcinogenic effect of NDMA. The rate of hepatic, pulmonary, and renal tumors has been shown to increase in rodents with inhalation of NDMA and consumption of drinking water containing NDMA.
NDMA is one of the most potent animal carcinogens known to date. It is a proven, potent carcinogen for all species that were studied, both in single doses and with long-term exposure to smaller quantities. Of note, NDMA seems to be metabolized in the same way in human tissue and rodent tissue. Because of this, the International Agency for Research on Cancer (IARC) classifies NDMA as probably carcinogenic to humans (Group 2A), highlighting that, for practical purposes, NDMA should be viewed as if it were carcinogenic to humans.
Furthermore, the National Toxicology Program (NTP) reasonably believes that NDMA is a human carcinogen, while the Environmental Protection Agency (EPA) calls it a probable human carcinogen.
In December 2020, a new study linked increasing NDMA levels to the degradation of molecules in Zantac. This new study, combined with Valisure's findings, shows that Zantac converted into high NDMA concentrations nearly 10 times the FDA's acceptable consumption limit for NDMA. They also found increased nitrate concentrations.
Ranitidine and Bladder Cancer
The main ingredient in Zantac is ranitidine hydrochloride. Ranitidine is classified as part of a group of antacid drugs known as H2 blockers. In 2004, the National Cancer Institute published a study linking bladder cancer with ranitidine use. A 2016 study illustrates the use of ranitidine significantly increases the presence of NDMA in urinary excretion. This was a groundbreaking study published in the medical journal Carcinogenesis.
We are already representing numerous Zantac bladder cancer victims. Dolman Law Group is investigating numerous links between women presently undergoing breast cancer treatment who used Zantac for an extended period of time. Prescription Zantac and its over-the-counter version contain what has been deemed to be unsafe levels of ranitidine and, as a result, NDMA.
FDA Investigation of Ranitidine NDMA Exposure
The FDA found, via testing, that the levels of NDMA in ranitidine increase over time, even when stored under normal conditions at room temperature. It was the mere fact that a known carcinogen could increase within ranitidine over a finite period of time that prompted the FDA to order Zantac to be taken off the shelves.
There is increasing data suggesting a correlation between ranitidine and cancer. Researchers at Memorial Sloan Kettering Cancer Center are presently studying the link between ranitidine and various types of cancer. They are attempting to uncover the answers to serious and concerning health questions, such as:
- Does Zantac cause cancer?
- What is the Zantac cancer risk?
What Cancer Does Zantac Cause?
Since over-the-counter Zantac and ranitidine contain high levels of NDMA, it may be linked to several types of cancers, including stomach cancer, intestinal cancer, bladder cancer, and breast cancer.
- Stomach cancer: This type of cancer forms over the course of many years. It is also known as gastric cancer and involves the abnormal growth of cells in the stomach. It can lead to difficulty swallowing, heartburn, nausea, and stomach pain. The five-year survival rate for individuals diagnosed with stomach cancer is 70 percent.
- Intestinal cancer: A high exposure to NDMA can cause cancer in the small and large intestines. It can include sarcomas, lymphomas, and carcinoid tumors. The survival rate depends primarily on whether cancer has a chance to spread to other parts of the body.
- Colorectal cancer: This type of cancer starts as a polyp in the rectum or colon. A polyp can grow into the rectum or colon wall over time, allowing cancer cells to infect blood and lymph vessels. Those infected vessels can carry disease to lymph nodes and the rest of the body. Larger polyps are more likely to cause cancer.
- Esophageal cancer: NDMA can cause cancer cells to develop in the tissues of the esophagus and lead to esophageal cancer. This is more common in men and can cause difficulty swallowing, chest pain, and heartburn. Thus, many of these individuals take even more Zantac or ranitidine to control.
- Bladder cancer: Bladder cancers are often diagnosed early and have a high success rate when treated. Symptoms of Zantac bladder cancer include blood in the urine and painful urination.
- Liver cancer: Liver cancer can happen as a result of cancer cells developing in the liver or migrating to the liver from other infected areas. Liver cancer patients may suffer from abdominal pain, as well as weakness and swelling in the abdomen. Liver cancer risk is increased with ranitidine use.
- Prostate cancer: The prostate is a walnut-shaped gland in the pelvis of men and can host cancer cells. Prostate cancer can lead to malignant growths, which serve as the second-leading cause of cancer death among men. This type of cancer is slow-growing and often results in erectile dysfunction and painful urination.
- Pancreatic cancer: One of the most lethal forms of cancer, claiming around 47,000 lives every year. It is often deadly because its symptoms aren't obvious and are typically not diagnosed until the later stages. Common symptoms include itchy skin, yellowing of the eyes, and abdominal pain.
- Breast cancer: This cancer involves the abnormal growth of cells within the breasts. Zantac use can increase the risk of developing ductal carcinoma, which requires cancer cells to grow in the breast ducts. This type of cancer affects more than 180,000 women every year. However, it can also affect men. Zantac can increase the risk of developing type of breast cancer known as ductal carcinoma.
- Throat/nasal cancer: This type of cancer occurs in the flat cells lining the throat. Symptoms include cough, voice changes, and sore throats. This is increased in individuals with GERD.
Other types of Zantac-related cancers include:
- Brain cancer
- Non-Hodgkin's Lymphoma
- Multiple Myeloma
- Islet cell tumors
- Kidney cancer
- Thyroid cancer
Zantac Breast Cancer Link
There is also anecdotal evidence that Zantac use might be linked to breast cancer. In 2008, a study showed that ranitidine and Zantac increased the risk of ductal carcinoma by more than two-fold. This increase occurred in both men and women. This is the most common type of breast cancer in the United States and accounts for 20 percent of all new cases.
In 2013, a Florida man filed a Zantac lawsuit alleging that the dangerous drug caused his breast cancer. Prior to his diagnosis, he took Zantac for four years regularly to treat his heartburn.
Zantac Liver Cancer Link
Our ranitidine cancer lawyers are presently investigating the link between numerous types of cancer and the use of Zantac. We strongly believe there is a causal link between Zantac and liver cancer. The CDC has expressly stated that NDMA can prove harmful to the livers of both humans and animals
The liver, along with our heart, is one of the most important organs. In fact, the liver serves to detoxify chemicals and filter blood passing through the body. Cancer cells often begin in other areas of the body and then spread to the liver. Symptoms of liver cancer include loss of appetite, upper abdominal pain, jaundice, vomiting and nausea, and white chalky stools.
We are presently representing many individuals who have been diagnosed with primary liver cancer as a result of Zantac use.
Common Zantac Cancer Symptoms
If you or someone you love takes Zantac or did in the past, it is crucial to be aware of cancer symptoms. Knowing these symptoms can potentially save your life. Contact your doctor to assess you for cancer caused by NDMA, so you can receive treatment before it worsens.
Common Zantac cancer symptoms include:
- Unintentional weight loss
- Poor appetite
- Nausea or vomiting
- Bloody or tarry stools (an indicator of intestinal bleeding)
- Light-colored or greasy stools
- A change in bowel habits
- Symptoms of anemia such as fatigue, dizziness, and weakness
- New abdominal pain unrelated to heartburn
- Back pain
- Yellowing of the skin or eyes
- Dark urine
- Blood in the urine
- Urinary urgency or incontinence
- Painful urination
- Itchy skin
If you are experiencing any of these Zantac cancer symptoms, see your doctor as soon as possible. Additionally, you will want to consult a product liability attorney if you have a history of prescription or over-the-counter use of Zantac or ranitidine.
The Damages Caused by Zantac Cancer
Those that have developed cancer as a result of taking Zantac typically contend with particularly severe damages. Cancer is one of the most damaging illnesses that one can suffer from, with each different kind inflicting its own specific brand of harm that can change a person's life. Regardless of the type of cancer one develops as a result of Zantac use, there are several damages that one will likely be able to claim in a product liability lawsuit regarding this dangerous drug.
Economic Damages Caused by Zantac Cancer
Even those with excellent health insurance coverage and savings to spare can end up financially ruined because of a cancer diagnosis caused by Zantac. The financial losses that are caused by an injury are known as economic damages and are the foundation of any personal injury lawsuit. One of the most serious economic damages caused by Zantac cancer is medical expenses. Treatment for cancer is notoriously expensive and can drain one's savings. In addition to initial treatment costs, there are recurring expenses like prescriptions, doctor appointments, and therapies.
People suffering from Zantac-caused cancer also may have to deal with lost wages they missed out on because of their illness. Earning potential, in general, can be ruined when someone is rendered unable to work because of Zantac. This can be worsened if they are a family breadwinner with many people depending on them.
The following are the economic damages you can seek compensation for caused by Zantac cancer:
- Medical expenses
- Lost wages
- Lost earning potential
- Cost of household services the person living with cancer cannot perform
- Wrongful death
Non-Economic Damages Caused by Zantac Cancer
Not all damages are as easy to calculate as economic damages like medical expenses or lost wages that simply require a look at some bills or pay stubs. There are many damages that do not directly cause financial losses and are known as non-economic damages. Zantac-caused cancer, or any cancer, often causes incredible pain, both physical and emotional in nature. This pain and suffering deserves compensation just as much as the economic losses caused by Zantac-related cancers.
Getting cancer from Zantac can cause a shock to the system, with a person's life-changing forever from that point on. Suffering from such a severe illness can affect a victim's ability to live a normal life. It can affect their daily life, mental health, and personal relationships.
You can seek compensation for non-economic damages caused by Zantac cancer. The following are some non-economic damages you could pursue compensation for in a Zantac cancer claim:
- Pain and suffering
- Loss of consortium
- Loss of enjoyment of life
- Emotional distress
- Loss of society
- Psychological injuries
Are You at Risk of Getting Cancer from Zantac?
Zantac can contain high levels of NDMA, consumption of which is found to increase the risk of cancer. NDMA exposure is suspected to increase the risk of several cancers, including tongue, esophagus, lung, pancreas, liver, kidney, and bladder cancers.
What are Your Chances of Getting Cancer from Zantac?
You should discuss your concerns about getting cancer from the use of Zantac with your doctor. There is no formula to determine what your risk might be. However, through animal testing, it is known that the higher doses and the longer exposures to NDMA increase the risk of test animals getting cancer. The incidence of liver tumors increased, and survival rates decreased in a dose-dependent manner when studied in lab rodents.
Ranitidine Cancer Risk
The FDA has requested that companies recall their ranitidine if testing shows levels of NDMA higher than the acceptable daily intake of 96 ng, or 0.32 parts per million for ranitidine. Although the FDA advisory states that the level of NDMA contamination is minimal in Zantac, some levels were 3,000 to 26,000 times more than what the FDA says is safe.
The amount of NDMA present in Zantac or ranitidine increases the longer the product is kept on shelves and if it is stored at higher than room temperature. Do you know if the Zantac you bought at Walmart was stored at room temperature or in a hot warehouse? Was the ranitidine you purchased at Walgreens on the shelf for months, or was it recently stocked? Once you get it home, how long does it stay in your medicine cabinet?
The longer the product is kept in storage, the higher the NDMA found in the tablets. This can increase your risk of getting bladder cancer, liver cancer, breast cancer, or even gastric cancer.
Zantac Recalls in the U.S.
Drug manufacturers may issue a voluntary recall to remove products that violate FDA regulations. Recalls protect public health from products that could present a risk of harm or gross deception by the drug manufacturer. Distributors and manufacturers can issue a voluntary recall at any time, although sometimes the FDA requests a recall. Either way, the FDA monitors the recall.
Multiple voluntary recalls have been issued for Zantac and ranitidine drugs. In mid-September 2019, the FDA announced to the public that NDMA was found in ranitidine samples. On September 24, 2019, the first voluntary recall was issued concerning this finding, and Sandoz ranitidine capsules were recalled. Two days later, a voluntary recall was issued for over-the-counter ranitidine tablets (both 75 mg and 150 mg), labeled and sold by Walgreens, Walmart, and Rite-Aid and manufactured by Apotex Corp.
In October 2019, two major drug companies, Apotex and Navartis, stated they were pulling all versions of generic ranitidine sold over-the-counter and via prescription throughout the U.S. Later that same October, pharmaceutical company Sanofi announced a voluntary recall of their over-the-counter ranitidine products Zantac 150, Zantac 150 Cool Mint, and Zantac 75.
Voluntary recalls were also issued for ranitidine oral solution from Lannett Company, Inc. and Novitium Pharma's 150 mg and 300 mg capsules. Between November 2019 and January 2020, an additional eight recalls of ranitidine products were issued.
When Do You Need to Hire a Zantac Cancer Lawyer?
If you believe your cancer was caused by Zantac or ranitidine, you may need the help of a Zantac Cancer Lawyer. In order to pursue your case, your Zantac lawyer will help you to prove 3 things:
You Used Zantac or Ranitidine
Those who are interested in pursuing compensation for cancer caused by Zantac will, of course, have to first prove that they actually took the medication Zantac or ranitidine. The easiest way to prove this would be to contact your doctor or pharmacy to get records of your prescriptions. If you bought the medication over-the-counter, it may be a little hard to prove that you took the medication, but through the help of your personal injury lawyer, it can be done using receipts and statements from your doctor.
You Have Contracted Cancer
Zantac and ranitidine are most commonly known to be harmful in the sense that they could cause cancer. So to file a claim, you will not only have to prove that you have cancer, but that the type of cancer you have is linked to NDMA. These two stipulations can easily be achieved with the help of your lawyer, doctors, and medical experts.
You Contracted Cancer After Using Zantac or Ranitidine
Proving that your consumption of Zantac or ranitidine is linked to your cancer is where all cases get tricky. Generally, there is information, studies, and experts that can all testify to the fact that the two are linked. But you must also show that you consumed enough of the medication for it to have been dangerous. There are two things that can help prove that your consumption of Zantac caused your cancer: how much of the medication you took and how long you took it.
The longer you took the medication, and the more of it you took, the more likely it is that your cancer and your consumption of the drug are connected. This connection will be further developed with the help of your legal and medical expert team. This is why it is so important to have an experienced Zantac Cancer Lawyer on your side.
What is the Statute of Limitations for a Zantac Cancer Claim?
The statute of limitations refers to how long the victim of a personal injury has to file a claim or lawsuit with the at-fault party. According to Florida Statute 95.11, a personal injury victim has four years from the incident that caused the personal injury to file a claim or lawsuit.
When the clock starts on the statute of limitations for a Zantac cancer claim can be tricky to know because it's challenging to perceive when the Zantac caused cancer. If you used it multiple times, it's near impossible to narrow down when you got cancer. Some companies have argued that the statute of limitations should start once the victim starts experiencing symptoms of cancer.
If you wish to file a Zantac cancer claim, you should consult with a Zantac cancer attorney as soon as possible. They can help you narrow down your window for filing the claim, as well as collecting evidence, proving the at-fault party's liability, and representing you in court.
Read What Leading Attorneys Say About Hiring a Zantac Cancer Attorney
We asked some of the top attorneys from around the country to answer an important question: “What are my legal rights if I've been diagnosed with cancer as a result of using Zantac?”
Here are their responses:
Steve A Barnes, Esq
On April 1, 2020, the FDA directed drug manufacturers to immediately withdraw from the market all Zantac and generic ranitidine drugs.
This followed a petition filed with the FDA by the online pharmacy company, Valisure, alerting the government to its findings of “extremely high levels of NDMA (a known carcinogen)... in every lot tested”.
NDMA is known to occur in many foods and beverages and is carcinogenic in very low doses. For this reason, the FDA has set acceptable daily intake of NDMA at 96 nanograms (96 billionths of a gram). Through its internal scientific studies, the online pharmacy, Valisure, reported that a single 150 mg Zantac (ranitidine) tablet produced 304,500 ng of NDMA, over 3,000 times the FDA recommended daily limit.
Why is this occurring? In its petition, Valisure concludes that the problem is not contamination of the drug. Instead, NDMA is likely formed in the body due to the inherent instability of the ranitidine molecule. This means that because of the way Zantac (ranitidine) is metabolized in the human body, NDMA is formed at unacceptable levels. A 2016 study at Stanford University found that patients taking 150 mg of Zantac had NDMA levels in their bodies exceeding 47,000 ng, nearly 500 times the FDA recommended daily limit. Since most of the NDMA would have been eliminated before reaching the urine, the level in the human body may have been much higher.
In 2011 a study was published in the American Journal of Clinical Nutrition which concluded that “dietary NDMA intake was significantly associated with increased risk of cancer in men and women and that “NDMA was associated with increased risk of gastrointestinal cancers.”
This was part of the European Prospective Investigation into Cancer and Nutrition (EPIC), one of the largest cohort studies in the world.
These are just a few of the scientific studies that should have been known to the manufacturer of ranitidine products like Zantac. There are others. If you have been diagnosed with cancers such as bladder, breast, kidney, prostate, thyroid, testicular, uterine, esophageal/throat, intestinal, liver, nasal, ovarian, pancreatic, or stomach you should reach out to a law firm with experience in handling these cases. Presently, all lawsuits have been consolidated into what is known as an MDL (Multi-District Litigation) in the Southern Federal District of Florida. Therefore, you should give serious consideration to retaining a Florida based law firm.
Whitney Butcher, Esq.
If you have been diagnosed with bladder, kidney, stomach, or another cancer after taking Zantac, you may be able to receive compensation for your medical expenses, time spent out of work, and physical pain and emotional suffering as a result of this cancer diagnosis.
The FDA recalled Zantac earlier this year due to the link between this medication and cancer, so if you have been diagnosed after taking the medication it is important to speak to an attorney to protect any legal rights you may have.
Ryan McKeen, Esq.
Medical device manufacturers and drug manufacturers have a duty to create products that are reasonably safe for consumers. Before a medicine is made available, companies may be required to extensively test a product and list all potential negative side effects related to the drug's intended use. Among the companies that must perform these tests is Sanofi, which produces the common heartburn medication Zantac.
On April 1, 2020, the United States Food and Drug Administration (FDA) issued a recall of Zantac and similar ranitidine products after N-Nitrosodimethylamine (NDMA) was found in the drug when handled under certain conditions. NDMA is classified by the FDA and other organizations as a probable human carcinogen.
Whenever a pharmaceutical company creates a product that results in negative effects from intended use, and they do not disclose these effects to the public, individuals harmed by that drug may have the ability to pursue compensation. Because of this, an individual who took Zantac or ranitidine, and later developed cancer, might be able to file a lawsuit.
Sol Weiss, Esq
In order to file a Zantac cancer lawsuit, you must have taken Zantac for more than 1 year, and been diagnosed with any one of the following types of cancer: bladder, esophageal, kidney, colon or rectal, intestinal, liver, pancreatic, prostate (in patients under 60), stomach, testicular, brain, or breast. The science behind why Zantac causes cancer is rapidly developing but it is understood well enough that attorneys across the US have already begun filing lawsuits.
Cases filed in Federal Court have been consolidated for all pretrial purposes before the honorable Judge Robin L Rosenberg in the Southern District of Florida. At Anapol Weiss, we are investigating Zantac cases for more than 1500 clients.
Our team consisting of four lawyers and four paralegals will review your medical records and proof of drug use to protect your legal rights against Sanofi and other makers of Zantac.
John Gomez, Esq.
Millions of heartburn sufferers relied on the over-the-counter and prescription versions of Zantac—or its generic equivalents sold as “Ranitidine” under brands from retailers like Walmart and CVS—to deal with the pain of heartburn. However, research has recently linked the brand name and generic drugs containing ranitidine to a variety of cancers. As a result, the U.S. government has ordered all drugs containing ranitidine pulled from the shelves. In the meantime, former users of the drug diagnosed with cancer are left facing a formidable diagnosis and questions about their legal rights and what to do next.
If you are facing a cancer diagnosis after prolonged Zantac or ranitidine use, you may have a legal right to compensation for your damages. If you retain a lawyer to represent you for your potential claim, your counsel could pursue damages for past and future medical expenses resulting from your injuries/diagnoses, past and future pain and suffering (physical and mental) caused by your injuries as well as the treatment and recovery process, past and future lost wages, past and future loss of earning capacity, past and future loss of enjoyment of life, and/or punitive damages, if appropriate and depending on applicable laws.
In April of 2020, the FDA announced that all Zantac brand heartburn drugs, prescription and over-the-counter, should be immediately pulled from the market because of potential NDMA (N-nitrosodimethylamine) contamination, a chemical linked to cancer. The manufacturers of Zantac and ranitidine had a responsibility to ensure that their products were reasonably safe and effective for consumer use. However, by manufacturing products containing a carcinogen at levels exceeding what is considered safe, these drug makers failed to meet that responsibility.
Consumer lawsuits filed throughout the country and coordinated in the Southern District of Florida's Multidistrict Litigation (“MDL”) allege that Zantac and ranitidine drugmakers manufactured, marketed, and sold a product they knew or should have known had been contaminated with an industrial chemical known to cause cancer. Despite their knowledge of this potential risk, the manufacturers of Zantac and ranitidine made the choice not to disclose this risk to the FDA or consumers. If you have been diagnosed with cancer after prolonged Zantac or ranitidine use, you have the right to hold the manufacturing drug company accountable and to monetary recovery for your injuries.
Jay Kelley, Esq.
The FDA reported the over-the-counter and prescription medication Zantac ( ranitidine) contains N-nitrosodimethylamine a cancer causing chemical when exposed to heat for even limited time, such as in a delivery truck.
Symptoms of exposure may include: fever, nausea, vomiting, jaundice, dizziness and/or cramping.
If an individual used Zantac for 5 years and has received a cancer diagnosis they may have a legal remedy available. The cases are proceeding in a Multi-district litigation ( MDL) currently. Clients with recent cancer diagnosis and a Zantac use history should contact an attorney to see if their diagnosis is entitled to compensation.
Stanley Gipe, Esq
If you have been diagnosed with cancer as a result of using Zantac you are not alone. The issue first came to light when the online pharmacy Valisure found unacceptably high levels of the probable cancer-causing substance N-nitrosodimethylamine (NDMA) in ranitidine products. Valisure is unique by testing every batch of drugs it sells for impurities. in 2019, Adam Clark-Joseph, cofounder of Valisure, ordered ranitidine syrup, prescribed to treat reflux in his young daughter. When the ranitidine tested positive for NDMA, Valisure began testing other drugs from other manufacturers.
“Every batch of every bottle of every manufacturer showed the same results, tremendously high formation of NDMA,” says CEO David Light. Ranitidine is sold in the United States under the brand name Zantac. The FDA took notice of these findings and issued a recall for Zantac in 2020. Prior to the recall recalled by the FDA, an estimated 15,000,000 Americans were taking prescription levels of Zantac and millions more were taking the over-the-counter version of the drug. With heartburn affecting an estimated 60,000,000 Americans annually, and millions more worldwide, Zantac became the best-selling drug in the world.
The recent scientific studies and the FDA recalls have caused many people to begin questioning whether or not Zantac caused their cancer. Lawsuits are currently being fought to get fair compensation for those diagnosed with cancer as a result of using Zantac and its generic equivalent.
If you have been diagnosed with cancer and have used Zantac in the past it is important to know you are not alone in this fight. Thousands of people just like you are pursuing their claims right now. The time frame for bringing a Zantac related cancer claim is limited and much of the work is already being done by firms currently litigating this issue. If you or a loved one were diagnosed with cancer after using Zantac your time to make a claim is limited. It is important that you team with a qualified Zantac cancer lawyer to represent you in this fight as soon as possible. "
Larry Nussbaum, Esq
Time and time again, large pharmaceutical companies are only worried about selling their products and turning large profits. As a result, we all suffer from the potential negative effects of these drugs such as Zantac. These companies know the dangers these drugs present. However, they continuously make the conscious decision to ignore the facts and hide the truth from the general public for their own selfish monetary gains. If you or a loved one has been diagnosed with cancer as a result of using Zantac, it was not accidental, but rather you are a victim. Our lawyers are here to help. You have a right to file a lawsuit and may be eligible for a large settlement.
Prior to taking Zantac, you should have been informed of all the risks and dangers associated with it; and a chance to make your own educated decision if the risks were worth it. Cancer is no joke and together we should all make the big manufacturers pay for their deceitful tactics. If you knew you could get cancer from taking Zantac, would you still have taken it? Regardless of how you may have answered the prior question, if you took Zantac and were diagnosed with cancer the time is now to contact a lawyer and make the pharmaceutical companies pay. We may not be able to rid you of cancer, but together we can stop this from happening to others in the future and get you financially compensated all at the same time.
Contact an Experienced Zantac Cancer Attorney
When you are suffering from an ailment, like heartburn or a headache, you have the right to assume the OTC medication in your cabinet is safe. Additionally, if you seek treatment from a medical professional and they prescribe you medication, you have a right to assume that what you are taking is safe and will work as intended.
Unfortunately, this is not always the case, and each year, people are injured by defectively manufactured prescription drugs, unknown chemicals, and negligent companies. In some cases, the injury is caused by a medical professional's negligence in prescribing a particular drug.
Drugs like Zantac have the potential to cause severe injuries to those that use them. The people suffering these illnesses deserve compensation for their damages. They can pursue damages if liable parties were negligent in not taking the proper precautions when making such a drug available. Dolman Law Group Accident Injury Lawyers, PA specializes in holding these groups accountable for their negligence and recovering settlements for those that have suffered because of this negligence.
Contact us today to get the compensation you deserve from a Zantac Lawsuit. We are handling Zantac cases nationwide and have formed relationships with fellow leading attorneys and law firms nationwide in order to assist victims in all fifty states. As a Zantac law firm, we will bring in local counsel when necessary to comport with the rules in each jurisdiction.
If you have been prescribed a medication that you believe may have caused an injury, please contact the attorneys at Dolman Law Group/Dolman Law Group Accident Injury Lawyers, PA for a free consultation today. You can reach our office by either calling (833) 606-DRUG  or contact us online. Our Zantac Cancer lawyers have the resources necessary to thoroughly investigate your claim and take on the biggest of corporate giants like Sanofi.
The Dolman Law Group works with local counsel in any jurisdiction outside Florida for the purpose of filing lawsuits in jurisdictions wherein we are not licensed. Thus, we will follow each State's ethical rules to ensure a local attorney is involved.
Dolman Law Group Accident Injury Lawyers, PA
800 North Belcher Road
Clearwater, FL 3375
(833) 606-DRUG